Basic Information
Basic information for OLMALINC-212-20aa
Peptide Name OLMALINC-212-20aa
Genome Position chr10:100388271-100388330[+]
Species Human
Peptide Sequence MIILPPFADSLFGLSPPAPR
Peptide Length 20
Unique No (OLMALINC-205-20aa,OLMALINC-209-20aa,OLMALINC-215-20aa,OLMALINC-216-20aa,OLMALINC-217-20aa,OLMALINC-218-20aa,OLMALINC-219-20aa,OLMALINC-220-20aa,OLMALINC-221-20aa,OLMALINC-226-20aa,OLMALINC-227-20aa,OLMALINC-228-20aa,OLMALINC-229-20aa)
Grand Average of Hydropathicity 0.675
Relative Molecular Mass 2481.82
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000235823;OLMALINC
Transcript ID/Name ENST00000657502;OLMALINC-212
Transcript Length 1015
Coding Ability 0.5054
DNA Sequence Corresponding to Peptide ATGATAATCCTACCACCCTTTGCTGACTCTCTTTTTGGACTCAGCCCGCCTGCACCCAGG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :